| Q67774884 | A Randomized Trial of Plasmapheresis and Subsequent Pulse Cyclophosphamide in Severe Lupus: Design of the Lpsg Trial |
| Q33344697 | An approach to evidence-based therapeutic apheresis |
| Q46071133 | Apheresis enhances the selective removal of antinuclear antibodies in systemic lupus erythematosus |
| Q33328904 | Apheresis for lupus erythematosus. |
| Q34227026 | Apheresis for lupus erythematosus: state of the art. |
| Q40113106 | Dermatologic therapy: December, 1980, through November, 1981 |
| Q34128942 | Dilated cardiomyopathy and autoimmunity: an overview of current knowledge and perspectives |
| Q73264874 | Effect of plasmapheresis on ligand binding capacity and expression of erythrocyte complement receptor type 1 (CR1) of patients with systemic lupus erythematosus (SLE) |
| Q54487219 | Effects of cyclophosphamide on autoantibody synthesis in the Brown Norway rat |
| Q38694115 | Immune complex assays: diagnostic and clinical application |
| Q31864034 | In vitro removal of human IgG autoantibodies by affinity filtration using immobilized L-histidine onto PEVA hollow fiber membranes |
| Q36334472 | Indications for plasma exchange in systemic lupus erythematosus in 2005. |
| Q41491500 | Internal medicine-important advances in clinical medicine: plasmapheresis as therapy |
| Q33614633 | New approaches to treating systemic lupus erythematosus |
| Q52936508 | Pilot clinical study of Adacolumn cytapheresis in patients with systemic lupus erythematosus. |
| Q33374604 | Plasma exchange for systemic lupus erythematosus |
| Q43732295 | Plasma exchange improves the glomerulonephritis of systemic lupus erythematosus in selected pediatric patients |
| Q33580268 | Plasmapheresis in clinical medicine. |
| Q33565413 | Rebound of anti-topoisomerase I antibody titres after plasma exchange |
| Q33562099 | Selective removal of anti-double-stranded DNA antibodies by immunoadsorption with dextran sulphate in a patient with systemic lupus erythematosus |
| Q37861069 | Successful treatment of patients with systemic lupus erythematosus complicated with autoimmune thyroid disease using double-filtration plasmapheresis: a retrospective study |
| Q58390460 | Systemic lupus erythematosus-associated diffuse alveolar hemorrhage: A case report and review of the literature |
| Q72684490 | The clinical effect and the effect on serum IgG antibodies to peripheral nerve tissue of plasma exchange in patients wit Guillain-Barré syndrome |
| Q38156510 | The mechanisms of action of plasma exchange. |
| Q38791636 | The treatment of lupus nephritis |
| Q71686478 | Therapeutic apheresis |
| Q33606753 | Therapeutic plasma exchange for the treatment of rapidly progressive glomerulonephritis |
| Q38082733 | Therapeutic plasma exchange: a technical and operational review |
| Q39587536 | Therapeutic plasmapheresis and plasma exchange |
| Q41854538 | Where now for therapeutic apheresis? |
| Q70571205 | [Treatment of generalized scleroderma by plasma exchange. Apropos of 3 cases] |